BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38679630)

  • 21. Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
    Wang MD; Li C; Li J; Zhang WG; Jiang WQ; Yu JJ; Xing H; Wu H; Han J; Li ZL; Xu XF; Chen TH; Zhou YH; Gu WM; Wang H; Zeng YY; Zhang YM; Pawlik TM; Lau WY; Wu MC; Yang JM; Shen F; Yang T
    Oncologist; 2019 Aug; 24(8):e730-e739. PubMed ID: 31127021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined measurements of tumor number and size helps estimate the outcome of resection of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
    Wang X; Wang Z; Wu L
    BMC Surg; 2016 Apr; 16():22. PubMed ID: 27094483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical treatment of metastases and its impact on prognosis in patients with metastatic colorectal carcinoma].
    Sevčíková K; Ušáková V; Bartošová Z; Sabol M; Ondrušová M; Ondruš D; Spánik S
    Klin Onkol; 2014; 27(1):38-44. PubMed ID: 24635436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients.
    Ruzzenente A; Capra F; Pachera S; Iacono C; Piccirillo G; Lunardi M; Pistoso S; Valdegamberi A; D'Onofrio M; Guglielmi A
    J Gastrointest Surg; 2009 Jul; 13(7):1313-20. PubMed ID: 19418103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical approach for extrahepatic metastasis of HCC in the abdominal cavity.
    Sano T; Izuishi K; Takebayashi R; Akamoto S; Kakinoki K; Okano K; Masaki T; Suzuki Y
    Hepatogastroenterology; 2011; 58(112):2067-70. PubMed ID: 22024077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study: clinical profile and prognostic factors of survival.
    Chagas AL; Felga GEG; Diniz MA; Silva RF; Mattos AA; Silva RCMA; Boin IFSF; Garcia JHP; Lima AS; Coelho JCU; Bittencourt PL; Alves VAF; D'Albuquerque LAC; Carrilho FJ;
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1148-1156. PubMed ID: 31247632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of hepatocellular carcinoma with extrahepatic metastases.
    Natsuizaka M; Omura T; Akaike T; Kuwata Y; Yamazaki K; Sato T; Karino Y; Toyota J; Suga T; Asaka M
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1781-7. PubMed ID: 16246200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
    Cai M; Huang W; Huang J; Shi W; Guo Y; Liang L; Zhou J; Lin L; Cao B; Chen Y; Zhou J; Zhu K
    Front Immunol; 2022; 13():848387. PubMed ID: 35300325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation.
    Bae HM; Lee JH; Yoon JH; Kim YJ; Heo DS; Lee HS
    BMC Cancer; 2011 Oct; 11():435. PubMed ID: 21985636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
    Ikai I; Arii S; Kojiro M; Ichida T; Makuuchi M; Matsuyama Y; Nakanuma Y; Okita K; Omata M; Takayasu K; Yamaoka Y
    Cancer; 2004 Aug; 101(4):796-802. PubMed ID: 15305412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.
    Li J; Hou Y; Cai XB; Liu B
    World J Gastroenterol; 2016 Apr; 22(15):4034-40. PubMed ID: 27099447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Analysis of Surgical Resection for Pulmonary Metastasis from Hepatocellular Carcinoma.
    Takahashi Y; Ikeda N; Nakajima J; Sawabata N; Chida M; Horio H; Okumura S; Kawamura M;
    World J Surg; 2016 Sep; 40(9):2178-85. PubMed ID: 27255943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors of palliative radiotherapy response and survival in patients with spinal metastases from hepatocellular carcinoma.
    Choi C; Seong J
    Gut Liver; 2015 Jan; 9(1):94-102. PubMed ID: 25071067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ALPPS procedure: hepatocellular carcinoma as a main indication. An Italian single-center experience.
    Vennarecci G; Ferraro D; Tudisco A; Levi Sandri GB; Guglielmo N; Berardi G; Sperduti I; Ettorre GM
    Updates Surg; 2019 Mar; 71(1):67-75. PubMed ID: 30255436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic efficacy of treatment for extrahepatic metastasis after surgical treatment of hepatocellular carcinoma.
    Imamura I
    Kurume Med J; 2003; 50(1-2):41-8. PubMed ID: 12971262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas >5 cm Without Extrahepatic Metastases: An Imaging-Based Retrospective Study.
    Li M; Xin Y; Fu S; Liu Z; Li Y; Hu B; Chen S; Liang C; Lu L
    Medicine (Baltimore); 2016 Jan; 95(2):e2458. PubMed ID: 26765441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy.
    Choi Y; Kim JW; Cha H; Han KH; Seong J
    J Radiat Res; 2014 Jan; 55(1):113-20. PubMed ID: 23772086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.